Sudoscan at the 11th Congress of the European Academy of Neurology (EAN) 2025 in Helsinki
Sudoscan participated in the 11th Congress of the European Academy of Neurology (EAN), on June 21 to 24, 2025, held at the Messukeskus Expo and Convention Centre in Helsinki, Finland, for the second year running.
With a focus on “Neurology within Society”, this congress highlighted the crucial role of neurology in addressing public health challenges and improving patient care worldwide.
“Neurology within Society”: The Core Theme of the 2025 EAN Congress
Organised annually by the European Academy of Neurology (EAN), this congress is a key event in the field of neurology, gathering more than 6,000 professionals including clinicians, researchers, industry experts, and policymakers from around the world. The goal: to exchange knowledge, share the latest scientific advances, and foster collaboration across the neurology community.
The 2025 edition will explore the theme “Neurology within Society”, highlighting the role of neuroscience in addressing societal challenges such as aging, healthcare inequalities, and public perceptions of neurological disorders. Topics of discussion included:
- Neurodegeneration: From genetics to pathogenesis to the beginning of mechanistic therapies
- How the brain represents the world
- Myoclonus, you need to know it to see it
- Protein aggregation and its relevance for neurodegenerative diseases
- Sleep by the brain, for the brain: Implications for neurology
- Multiple sclerosis, from biology to clinical translation. A focus on nodes of Ranvier and electrical activity
Sudoscan at EAN 2025: Supporting Neurological Care
Sudoscan will be on-site to showcase how its medical technology supports the detection and management of various neurological conditions. By measuring electrochemical skin conductance, Sudoscan evaluates sudomotor function, which reflects the health of small nerve fibers that control sweat gland activity. This method is particularly valuable for identifying small fibre neuropathies, which can be associated with conditions such as Hereditary Amyloidosis, Autoimmune Neuropathies, and Parkinson’s Disease.
Sudoscan’s diagnostic solution is:
- Fast: no patient preparation required, results in 3 minutes
- Non-invasive: safe, painless, and easy to operate
- Evidence-based: supported by numerous peer-reviewed scientific publications